Defective hepatitis B virus (HBV) genomes derived from packaging and reverse transcription of spliced RNA pregenomes were reported to be associated with progression to chronic infection. Since only two types with similarly spliced regions were characterized so far we reasoned that additional ''spliced'' genome variants may exist. Therefore, we isolated a large number of defective HBV genomes from sera of seven chronic carriers by full-length PCR. Forty-eight were found to contain deletions caused by splicing as identified by cloning, subgenomic PCR, and sequencing. In total, 11 types of spliced genomes derived from excision of 10 different introns were present in various combinations in each serum. This diversity resulted from alternative usage of five splice donor and four acceptor sites present in most but not all HBV genotypes. All spliced genomes shared sequence elements essential for replication as well as for transcription of the pre-C and pregenome/C mRNAs and the X mRNA. Moreover, all contained the coding regions for the X protein and for precore/core or precore/ core fusion proteins but lacked the pre-S/S gene promoters. These data demonstrate substantial and HBV genotypedependent diversity of spliced genomes from which a variety of aberrant precore/core fusion proteins and normal X protein but no functional envelope and P proteins could be expressed. These genomes and the encoded proteins may play a role in the viral life cycle, persistence, and pathogenesis.
INTRODUCTION
spliced RNAs) was identified in HBV DNA-transfected cell lines, in HBV-transgenic mice, and in HBV-infected Hepatitis B virus (HBV) infection causes a variety of liver (Chen et al., 1989; Su et al., 1989a,b; Suzuki et al. , liver diseases in humans. The clinical manifestations 1989 The clinical manifestations , 1990 Choo et al., 1991; Kajino et al., 1991; Wu et range from acute, fulminant, to chronic hepatitis; liver al., 1991) . The simultaneous synthesis of spliced and cirrhosis; and hepatocellular carcinoma. Most HBV geunspliced HBV transcripts is reminiscent of the situation nomes in virions consist of a small partially doublein HIV. Furthermore, HBV RNAs have a posttranscripstranded circular DNA which is converted into covalently tional regulatory element (PRE) ( Fig. 1 ) (Huang and Liang, closed circular (ccc) molecules in nuclei upon infection 1993; Huang and Yen, 1994, 1995) , which seems to be of cells. The ccc HBV DNA serves as template for synthefunctionally similar to a HIV RNA sequence element, dessis of a set of viral transcripts, namely a 3.5-kb pre-C ignated rev response element (Emerman et al., 1989 ; mRNA for translation of precore/HBe protein, a 3.5-kb Hadzopoulou-Cladaras et al., 1989; Malim et al., 1989) . pregenome/C mRNA coding for nucleocapsid and P proIn HIV, and possibly also in HBV, the elements posttrantein, 2.4-and 2.1-kb pre-S/S mRNAs coding for surface scriptionally regulate the ratio of spliced to nonspliced proteins (HBs, pre-S1, and pre-S2 proteins), and a 0.9-mRNAs. It is therefore well conceivable that spliced kb mRNA presumably coding for the X protein. All these RNAs of HBV play a role in the life cycle of the virus. transcripts are unspliced, have different 5-ends, and
From the two major types of spliced HBV RNAs known share the same 3-end located at the unique polyadenylso far, a single intron or two introns are removed (exon ation/processing site of the HBV genome. Only the pregeboundaries at positions 2447/489 and 2067/2350 / 2447/ nomic RNA which contains a functional encapsidation 282, respectively; see Fig. 1 ) (Chen et al., 1989; Su et al. , signal at its 5-end is encapsidated into core particles 1989a; Suzuki et al., 1989; Choo et al., 1991; Wu et al. , and reverse transcribed into progeny HBV DNA (for a 1991). In addition, in two minor spliced transcripts the recent review see Ganem, 1996) . regions between positions 2985 and 489 and positions In addition to these unspliced transcripts, a variable 2471 and 489 are removed ( Fig. 1 ) (Suzuki et al., 1990) . fraction of spliced 3.5-kb pre-C and pregenome/C From these four spliced pregenomic RNAs only two mRNAs (up to more than 50% of the corresponding un-(2447/489 and 2471/489) were detected in the form of reverse-transcribed DNA in virions (Terre et al., 1991) . genomes exist and whether or not they share common features with those variants proposed to play a role in viral persistence and pathogenicity. Therefore, we isolated and characterized a large number of such genomes from serum of seven chronically infected patients. Here, we demonstrate that the types of defective genomes derived from spliced pregenomic RNA are much greater than known so far and that most of them could only express X protein and aberrant core fusion proteins.
MATERIALS AND METHODS

Isolation of DNA from serum
Sera were from seven highly viremic patients with hepatitis B surface antigen-positive chronic hepatitis. From each serum sample, 300 ml was incubated at 65ЊC for 4 h in 20 mM Tris-HCl (pH 8.0), 10 mM EDTA, 0.1% SDS, and 0.8 mg/ml proteinase K. The DNA was then extracted with phenol and subsequently with chloroform and precipitated with ethanol using 20 mg tRNA as carrier. The pellet was dissolved in 20 ml H 2 O. Serum HBV DNA was amplified as described previously (Gü nther et al., 1995) by PCR in 50 ml buffer ited and only a subfraction of spliced pregenomic RNAs containing 50 mM Tris -HCl (pH 8.3), 50 mM KCl, 1.5 may be encapsidated and reverse transcribed. AlternamM MgCl 2 , 200 mM dNTP, 0.01% gelatin, 5 U Taq DNA tively, there may be many more functional splice sites polymerase (Boehringer Mannheim, Germany), and 1 which have not been detected so far.
mM primer P1 and P2 (P1, CCGGAAAGCTTGAGCTCTSplicing of the pregenomic RNA is not unique for HBV TCTTTTTCACCTCTGCCTAATCA; P2, CCGGAAAGCbut was also observed for the related woodchuck and TTGAGCTCTTCAAAAAGTTGCATGGTGCTGG; HBV hoduck (DHBV) hepatitis viruses (Hantz et al., 1992 ; Ogston mologous sequences span nucleotides 1821 -1841 and and Razman, 1992 Obert et al., 1996) . Moreover, a 1823 -1806, respectively; see Fig. 1 for position on the spliced version of the DHBV pregenomic RNA was shown HBV genome; SstI sites used for cloning are underto be essential for productive infection of ducks but dislined). A 45-ml reaction premix was heated to 80ЊC and pensable for virus replication when DHBV DNA was intro-5 ml enzyme was then added. The amplification was duced into hepatoma cell lines by transfection (Obert et performed for 20 to 30 cycles, depending on the amount al., 1996). Similarly, the major types of spliced pregenoof template DNA, at 94ЊC for 40 s, 60ЊC for 1 min, and mic HBV RNAs are dispensable for virus replication when 72ЊC for 4 min with an increment of 5 s per cycle in a tested by transfection of cells with HBV DNA (Su et al., Perkin -Elmer thermocycler (48 wells). The PCR prod1989a; Wu et al., 1991) , but a function in vivo is not exucts were purified by phenol/chloroform (1/1) extraction cluded. In fact, it was suggested that defective genomes and digested with SstI for at least 6 h. The cleaved DNA derived from the major singly spliced RNA (2447/489) was separated on an agarose gel; fragments between play a role in virus persistence because they were found 1.0 and 3.0 kb were recovered from the gel and cloned predominantly in sera of patients with chronic infection into pUC19. and much less frequently in those with an acute selflimited course (Rosmorduc et al., 1995) . Moreover, these
Analysis of cloned HBV DNA by PCR and sequencing genomes were shown to express much higher levels of core and HBe proteins and of X gene transcripts than a
The cloned HBV genomes were PCR amplified as described above using 1 ml of bacterial glycerol stock culwild-type genome in transfection experiments, which was speculated to be eventually important for immune ture and primers P1/P2. The resulting PCR products were diluted 1:50 and 1 ml thereof was used as template for recognition of the virus, viral persistence, and pathogenicity (Rosmorduc et al., 1995) . In this report we adamplification of subgenomic fragments in a 25-ml assay with 0.1 mM primer combinations P1/P3 (P3: 2400-2381, dressed the question whether additional ''spliced'' HBV as the ratio between the 3.2-kb and the shorter PCR products differed between the samples. Thus, each serum sample seems to contain a characteristic set and amount of short genomes. The short genomes always constituted only a small fraction of the virus population as evident from the lower intensity of the corresponding bands and their more efficient amplification compared to wild-type genomes. The latter was experimentally demonstrated by amplification of a mixture of HBV DNAs 1.2 and 3.2 kb in length. The 1.2-kb HBV genomes were shown). Therefore, even in sample b, which showed a stained by ethidium bromide. The same pattern and relative amounts 1:1 ratio of full-length to short PCR fragments (Fig. 2) , the of short genomes were found when the PCR was repeated with the same samples (not shown).
latter represent only a minor HBV genome subpopulation.
Cloning and PCR analysis of defective HBV genomes CTTCGTCTGCGAGGCGAGGG), P4/P5 (P4: 2357-2380, For the analysis of the structure of the short HBV ge-GGCAGGTCCCCTAGAAGAAGAACT; P5: 738-716, ATAnomes, the amplified DNAs in the 1.0-to 3.0-kb length ACTGAAAGCCAAACAGTGGG), and P6/P2 (P6: 634-656, range were recovered from the gel and cloned into vector ATTCCTATGGGAGTGGGCCTCAG). The positions of the pUC19. Recombinants were obtained from all serum primers are indicated in Fig. 1 . The plasmid DNA of 34 samples and 55 plasmids were randomly chosen for a representative clones was prepared and the HBV DNA further structural analysis. The approximate sizes and insert was sequenced with vector-specific reverse and locations of deletions were first roughly mapped by three forward primers and primer P4 using the SequiTherm overlapping subgenomic PCRs covering the whole geLong-Read Cycle Sequencing Kit (Epicentre Technolonome and agarose gel analysis of the PCR fragments. gies, Madison, WI) and an automated sequencer (LI-
The primers chosen for this screening hybridized outside COR, Lincoln, NE).
of the intron sequences of the previously described singly and doubly spliced pregenomic RNAs ( Fig. 1 ) be-RESULTS cause we expected that a large fraction of molecules is derived from spliced pregenomic RNA. This subgenomic Amplification of full-length HBV genomes from sera PCR screen revealed various large deletions between nucleotide positions 2357 and 738 in HBV genomes of HBV DNA was isolated from sera of seven chronically HBV-infected patients and amplified by PCR. In order to most of the plasmids (for representative examples see Fig. 3 ), in some cases with additional adjacent deletions obtain the entire length of the HBV genomes, primers annealing at the very 3-and 5-ends of the HBV DNA in the C gene. The PCR analysis of individual genomes from sample e, for example, even revealed five different minus strand were used as described previously ( Fig. 1 ) (Günther et al., 1995) . After separation of the PCR prodtypes of deletions located between positions 2357 and 738 (Fig. 3 , patient e, lanes 1 to 5). Deletions identical in ucts in an ethidium bromide-stained agarose gel, a major band corresponding to HBV genomes of 3.2-kb wild-type length in some genomes from one as well as from different patients were also found (Fig. 3 , patient d, lanes 1-length was visible in all samples (Fig. 2) . In addition, DNA with faster electrophoretic mobility corresponding 5, 7, and 9; patient e, lanes 1, 6, and 7). In a few cases, no DNA fragments were amplified with the primers used, to molecules 1.5 to 3.2 kb in length was seen in all but one sample, suggesting the presence of HBV genomes indicating deletions or mutations of the primer binding sites in these genomes as experimentally confirmed becontaining large deletions (Fig. 2) . Such genomes shorter than full-length HBV were not observed after amplificalow. In conclusion, the PCR analysis revealed the presence of one or more large internal deletions between tion of cloned wild-type HBV DNA (data not shown), indicating that they occur in vivo and are not artificially crethe 5-end of the C gene and the 3-end of the S gene and that the population of defective genomes can be ated by PCR. In samples a, b, and f the HBV ''deletion'' variants showed up as rather distinct bands, indicating highly heterogeneous in the serum of an individual. dominant size classes of defective genomes (Fig. 2) . In
Detailed structural analysis of defective HBV contrast, a diffuse banding pattern was observed in samgenomes ples d, e, and g, suggesting the presence of a much more heterogeneous population of such genomes. Fur-
The precise structures of the defective genomes were determined by sequencing. To avoid redundant sequencthermore, the length of the short PCR products as well FIG. 3 . Size analysis of deletions in cloned defective HBV genomes derived from patients d and e. Subgenomic fragments of nine cloned defective genomes from each patient were amplified using primer combination P4/P5 spanning nucleotides 2357 to 738 ( Fig. 1 ) and were separated in an agarose gel and stained by ethidium bromide. WT, cloned wild-type HBV DNA (Galibert et al., 1979) was used as a template for PCR. The splice donor and acceptor sites which delimit the deletions are indicated. The ''splice'' types of those cloned genomes whose sequences have been determined (see Fig. 5 ) are indicated below the lanes.
ing of identical types of genomes, the defective genomes parts of the P and pre-S/S proteins and containing the complete pre-S1 (region 1) and pre-S2/S (region 2) profrom each serum sample were first classified according to position and length of the deletions by subgenomic moters (Fig. 5, bottom) . The structures of the defective genomes indicate that PCR analysis as described above. One or two genomes representative of each genome class from each serum 10 different intronic sequences are removed from the corresponding RNA pregenomes. The diversity in strucwere sequenced completely (in total 34 of the 55 cloned genomes). In 27 of the 34 sequenced genomes, repreture is caused by alternative usage of five different splice donor and four splice acceptor sites (Fig. 4) . Another sentative of 48 of the 55 cloned defective genomes, splice donor/acceptor site-specific sequences were reason is the removal of more than one of these introns as evident in genomes 2, 4, 7, and 10, with two introns identified at the deletion boundaries, indicating that the deleted sequences correspond to introns removed from removed, and in genome 8, lacking three intronic sequences (Fig. 5) . The number and types of genomes idenpregenomic RNA (Fig. 4 ). In total, 11 different types of defective genomes derived from spliced pregenomic tified in our study indicate that the various splicing sites differ also quantitatively in their function. The most fre-RNA were found (Fig. 5) . Although these 11 types differ drastically in structure, they share some common feaquently used splice donor site was at position 2447 (in 83% of the spliced genomes), approximately one-third as tures. In particular, all defective genomes share sequences from nucleotide position 489 to position 2067 frequent was that at position 2067, and the remaining three at positions 2087, 2471, and 2985 were rarely func- (Fig. 5, bottom) . This region contains all known signals required for conventional replication (DR1 and DR2), syntional (Fig. 4) . A similar analysis for the four acceptor sites revealed most frequent splicing at position 489 (in thesis and processing of pregenomic/C-mRNA, pre-C mRNA, and X mRNA (C and X gene promoter, enhancer I 79% of the spliced genomes). Acceptor sites at positions 282 and 2350 were involved in every fifth spliced genome and II, polyadenylation/processing site), and pregenomic RNA encapsidation (Fig. 5, bottom) . The presence of the and splicing at position 2902 was 10 times less frequent than at the most prevalent one (Fig. 4) . RNA encapsidation signal and of the direct repeat sequences is consistent with the isolation of the defective
In view of the quantitative differences in splice site usage we wondered whether this depends on the degree HBV genomes from serum-derived viral particles. Furthermore, common to all genomes is the presence of the of homology of the HBV splice sites with the splice consensus sequences or on genotype-specific sequence complete X protein coding region and the complete C ORF or truncated versions thereof fused to other ORFs variation within these sites. This analysis revealed a similar degree of homology of the different HBV splice sites (Fig. 5) . All genomes lack sequences in two regions (positions 2471 to 2902 and 2985 to 282), both coding for with the consensus sequences (Fig. 4) . From the minor signals (Fig. 4) . With one exception, all of these changes are consistent with the splice consensus sequences, but an influence of some of them on recognition by the splicing apparatus is conceivable. The exception concerns the splice donor site at position 2087. In HBV genotypes A, D, and E there is a G residue instead of a T or C in the invariable /2 position of the splice consensus sequence which should inactivate this splice donor site in these genomes. This is consistent with our observation that spliced genomes generated via this splice site did not belong to any of these genotypes but were exclusively of genotype B.
DISCUSSION
In this study we provide evidence for the existence of a large variety of defective HBV genomes derived from spliced pregenomic RNA (HBV splice variants). Sequence analysis revealed four donor and five acceptor splice sites used in different combinations and frequencies depending in part on the HBV genotype. The splice variants represented a minor population compared to wild-type genomes, and their relative amounts and types seem to differ from patient to patient. Common to all the splice variants was the presence of the X gene and all known regulatory sequences required for pre-C and pregenome/C mRNA synthesis and genome replication. In contrast, all lacked the pre-S/S gene promoter regions and contiguous coding regions for the envelope and P proteins. The C gene was fused in most genomes with other reading frames. These findings indicate a more complex splicing of pregenomic HBV RNA than known so far and may imply a role of the corresponding splice variant genomes and expressed proteins in the viral life (Mount, 1982; Zeitlin and Efstratiadis, 1984; Jackson, data obtained extend previous investigations based on 1991) . Invariable nucleotide positions are boxed. Only one possible subgenomic PCRs which led to the identification of ''sinbranch site which most perfectly matches the consensus is indicated. gly spliced'' genomes of types 1 and 6 in serum but Pyrimidine residues forming the polypyrimidine tract located between failed to detect other spliced genomes (Terre et al., 1991;  the putative branch site and the 3-splice site are underlined. HBV genotype-specific nucleotide changes in splice signals are indicated Rosmorduc et al., 1995) . In agreement with these reports, below the sequences and the corresponding genotype is given in pawe also found splice variants in different relative rentheses. Genotype-specific AGs are also indicated (encircled) beamounts in individual samples and only as minor populacause they may serve as alternative 3-splice sites or inhibit splicing tions consisting predominantly of defective genomes of as reported in other systems (Smith et al., 1989) . The frequency of use type 1. The latter accounted for 50% of all splice variant of a specific splice site was calculated by dividing the number of genomes spliced at this site by the total number of genomes analyzed genomes analyzed and were present in sera from five of (n Å 48). seven patients. All other splice variant genomes were much less prevalent and this may be one reason why they have not been detected before. differences in homology no association with the frePreviously described splice sites and the HBV genoquency of splicing at a specific site can be inferred.
type-specific splice donor site 2087 identified in our study Interestingly, a sequence data bank search uncovered genotype-specific sequence variation within the splice sum up to five donor and four acceptor sites used for splicing of pregenomic RNA. The donor sites 2067 and highly conserved. A notable exception is a genotypespecific T to G mutation in position /2 of the splice 2447 and the acceptor sites 2350, 282, and 489 are frequently involved in pregenomic RNA splicing (Chen et donor site 2087 which is not compatible with splice site recognition (Mount, 1982; Jackson, 1991) . Mutations outal., 1989; Su et al., 1989a; Suzuki et al., 1989; Choo et al., 1991; Wu et al., 1991) , whereas splicing was rarely side of splice site recognition sequences, such as the deletions in the C gene of some of the genomes studied detected at the donor site 2985 and occurred only after inactivation of the 2447 donor site at a cryptic site at or the HBV genotype-specific insertions close to the 2350 and 2902 acceptor sites, may also influence splice site position 2471 (Suzuki et al., 1990) . Based on the deletion of nucleotides 2448 to 2901 in chromosomally integrated selection by altering the RNA structure. Provided splicing in HBV is functionally important, the presumed HBV geno-HBV DNA from the human hepatoma cell line PLC/PRF/ 5 (Ziemer et al., 1985) , the existence of a functional donor type-specific variation in splicing and the complex pregenomic RNA splicing patterns observed may imply that site at position 2902 was so far only suggested (Terre et al., 1991) . Our study demonstrates the function of the some splice sites are functionally redundant, e.g., they could have the same effects. In this case, knockout of splice site at position 2902 and suggests moreover that the HBV DNA integrated in these cells arose from infecspecific sites would be tolerable. This conclusion does not exclude an essential function of a subset of splice tion with a corresponding splice variant. Thus, splice variant genomes may also play a role in hepatocarcinosites for some aspects of infection. Consistent with the latter speculation is the use of the splice acceptor sites genesis. Strikingly, most of the splice sites which gave rise to the defective genomes described here were pre-282 and 489 in all genomes. These two sites may be functionally important for the HBV life cycle. viously identified on the RNA level, but in only 3 of the 11 splicing patterns, namely types 1, 6, and 10. The splicing An intriguing observation is the apparent absence of splice sites downstream of position 489 and upstream patterns 1, 10, and 6 correspond to the most prevalent singly and doubly spliced pregenomic RNAs (Chen et al., of position 2067. This may be due to the lack of such splicing sites, to too low sensitivity of our assays, or to 1989; Su et al., 1989a; Suzuki et al., 1989; Choo et al., 1991; Wu et al., 1991) and to the rare variant in which the fact that we have analyzed only genomes greater than 1.0 kb. Since very small HBV genomes could be splicing occurs at the cryptic site at position 2471, respectively (see Fig. 1 ) (Suzuki et al., 1990) . generated if splicing started in the C gene and extended up to the X gene region, we analyzed in an independent It is not clear why the efficiency and type of splicing differs from patient to patient. One possible reason could study amplified HBV DNA fragments smaller than 1.0 kb by cloning and sequencing of PCR fragments. In these be sequence variations which create, destroy, or modulate the function of splice signal sequences. Four seexperiments, defective genomes with extremely large deletions were found but none was generated by splicing quence elements on the RNA are important in the splicing process: the 5-splice site (consensus: MAG/ (G.S., unpublished observation). Therefore, we currently believe that there are no splice sites downstream of posi-GTRAGT), the 3-splice site (consensus: YAG/G), and the branch site (consensus: YNYYRAY) 20-50 nucleotides tion 486 and upstream of 2067. Taking our and previously published data (Chen et al., upstream thereof, as well as a polypyrimidine tract between the 3-splice and the branch site (Mount, 1982; Su et al., 1989a; Suzuki et al., 1989 Suzuki et al., , 1990 Choo et al., 1991; Terre et al., 1991; Wu et al., 1991) together it is Zeitlin and Efstratiadis, 1984) . All HBV splice donor and acceptor sites identified in our study are in close agreeevident that both the pre-C and the C mRNAs can be extensively spliced. As a consequence a large number ment with these consensus sequences. However, we noted that they differ in some HBV genotypes which may of aberrant precore and core fusion proteins are presumably expressed from these RNAs. Some of these proteins have quantitative and qualitative effects on the splicing of the genotype-specific RNA pregenomes. This speculacould negatively interfere with the viral assembly process as shown for artificial core fusion proteins (Scaglioni et tion needs to be experimentally examined because the sequences involved in splice site recognition are not al., 1994 von Weizsäcker et al., 1996) . Such defec-
FIG. 5.
Types of defective HBV genomes classified according to the splice pattern. Deletions generated by splicing are indicated by thin lines, whereas in-frame deletions in the C gene which do not result from splicing are shown as a dashed line. Nucleotide positions at the exon boundary and the lengths of deletions calculated on the basis of the genotype D wild-type genome (Galibert et al., 1979) with numbering starting in the middle of the EcoRI site are given. Note. Positions or lengths are different in other genotypes due to genotype-specific insertions. Conventional and novel open reading frames (ORFs) present in each type of genome are shown and capital letters indicate the origin of each part of these ORFs with respect to the conventional HBV ORFs (C, P, S, and X as shown on top), whereas nonconventional ORF parts are filled. The nonconventional 3-ORF parts in types 1, 4, 6, 7, 9, and 11 terminate in a genotype-specific manner at heterogeneous positions as indicated by multiple arrows at the end of these frames. HBV sequences and regulatory DNA and RNA elements shared by (black boxes) and lacking in all (interruptions) spliced genomes are schematically shown at the bottom line. DR1 and DR2, direct repeat sequences; S1p and S2p, S gene promoters; Xp, X gene promoter; EnI, enhancer I; Cp/EnII, C gene promoter/enhancer II; pA, processing/polyadenylation signal; e, RNA encapsidation signal.
tive proteins are predictably abundant in the cell relative can synthesize ccc DNA and a corresponding pregenome-like RNA, they could presumably replicate indefito the nondefective proteins since a large fraction and sometimes even most of the pre-C and C mRNAs are nitely when supplemented in trans with the essential virus proteins from wild-type virus. This may contribute spliced in infected liver and in HBV DNA-transfected cells (Chen et al., 1989; Su et al., 1989a,b; Suzuki et al., 1989, to their accumulation and, consequently, to enhanced expression of X protein and of aberrant core proteins. 1990; Kajino et al., 1991; Wu et al., 1991) . Their predicted abundance makes them ideal candidates for acting as
The data presented and the clones obtained in our study provide the basis to prove or disprove these predictions inhibitors of virus multiplication similarly to defective interfering particles (Holland, 1990) . A carboxy-terminal P as well as the possible role of the splice variants in the viral life cycle, persistence, and pathogenesis. (fusion) protein with RNase H activity could eventually be translated from all spliced pregenomic/C mRNAs provided that translational scanning occurs as shown for ACKNOWLEDGMENTS the P ORF in wild-type C mRNA (Fouillot et al., 1993) .
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It is also conceivable that the splice sites in the pre- level of the unspliced transcripts (Su et al., 1989a; Wu et Virol. 63, 4165-4171. al., 1991) argues against this possibility. In addition, the Choo, K. B., Liew, L. N., Chong, K. Y., Lu, R. H., and Cheng, W. T. (1991) .
Transgenome transcription and replication in the liver and extrahe-PRE present on both RNAs (see Fig. 1 the complete X gene, including its promoter region, the
